You are here

blood thinners

J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses

Fierce Pharma

Tue, 11/14/23 - 09:56 pm

peripheral artery disease

Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report

Fierce Pharma

Tue, 06/14/22 - 08:57 pm

Bristol Myers Squibb

Bristol Myers and Janssen race toward PhIII with a next-gen blood thinner

Endpoints

Mon, 11/15/21 - 12:33 pm

Bristol Myers Squibb

Full Brilinta study results show the blood thinner reduces rate of secondary stroke

Endpoints

Thu, 07/16/20 - 10:40 am

clinical trials

Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke

Fierce Biotech

Thu, 04/18/19 - 09:57 am

In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa

Endpoints

Fri, 05/4/18 - 10:13 am

Portola Pharmaceuticals

Judge orders 1,200 Xarelto liability cases to be prepped for trials

Fierce Pharma

Sat, 03/10/18 - 09:11 am

J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin

Fierce Pharma

Thu, 11/16/17 - 09:41 am

coronary artery disease

Bristol-Myers, Pfizer continue to build case for Eliquis

BioPharma Dive

Tue, 08/29/17 - 09:49 am

Bristol-Myers Squibb

With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC

Fierce Pharma

Thu, 08/24/17 - 11:25 am

Abbott to study blood thinners after treatment with Xience drug-eluting stent

Drug Delivery Business News

Wed, 07/26/17 - 12:10 am

Bristol-Myers Squibb Saw Improved Eliquis Sales in 3Q16

Market Realist

Mon, 11/28/16 - 11:27 pm

Bristol-Myers Squibb

AstraZeneca: Despite Brilinta's Trial Miss, Long-Term Holds Potential

Seeking Alpha

Wed, 10/12/16 - 11:16 am

U.S. FDA clears Xarelto blood thinner despite faulty trial device

Yahoo/Reuters

Tue, 10/11/16 - 09:38 pm

FDA rejects Eagle Pharma's reformulated Angiomax

Fierce Biotech

Mon, 03/21/16 - 09:02 am

Eagle Pharmaceuticals

J&J blood thinner under review for trial overseen by FDA nominee Califf

Stat

Wed, 12/9/15 - 11:44 am

Boehringer says Pradaxa blood-thinning effect shown to be reversible

Yahoo/Reuters

Mon, 06/22/15 - 10:39 am

Boehringer Ingelheim

Bristol-Myers recalls six lots of blood thinner injection

Yahoo/Reuters

Tue, 07/1/14 - 01:03 pm

Bristol-Myers Squibb

Pradaxa files show drug marketers weighing in on how to communicate the drug's risks

Fierce Pharma

Fri, 02/7/14 - 10:50 am

Boehringer Ingelheim

Boehringer's blood clot drug shows promise in broader use trial

Yahoo/Reuters

Tue, 12/17/13 - 10:58 am

Boehringer Ingelheim

Pages